UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Potential applications of nanotechnologies to Parkinson's disease therapy

Parkinsonism & related disorders, 2008-01, Vol.14 (5), p.383-392

Linazasoro, G

2008

Volltextzugriff (PDF)

A global view of Parkinson's disease pathogenesis: Implications for natural history and neuroprotection

Parkinsonism & related disorders, 2009-07, Vol.15 (6), p.401-405

Linazasoro, G

2009

Volltextzugriff (PDF)

Classical Parkinson disease versus Parkinson complex - Reflections against staging and in favour of heterogeneity

European journal of neurology, 2007-07, Vol.14 (7), p.721-728

Linazasoro, G.

2007

Volltextzugriff (PDF)

Imaging beta-amyloid burden in aging and dementia

Neurology, 2008-04, Vol.70 (18), p.1649; author reply 1650-1650

Linazasoro, G

2008

Volltextzugriff (PDF)

The phenotypic spectrum of rapid-onset dystonia-parkinsonism (RDP) and mutations in the ATP1A3 gene

Brain (London, England : 1878), 2007-03, Vol.130 (3), p.828-835

2007

Volltextzugriff (PDF)

Conversion from dopamine agonists to pramipexole: An open-label trial in 227 patients with advanced Parkinson's disease

Journal of neurology, 2004-03, Vol.251 (3), p.335-339

LINAZASORO, G

2004

Volltextzugriff (PDF)

Classifying risk factors for dyskinesia in Parkinson’s disease

Parkinsonism & related disorders, 2010-09, Vol.16 (8), p.490-497

2010

Volltextzugriff (PDF)

Rate of progression determines the clinical outcome after neural transplantation in Parkinson's disease

Brain (London, England : 1878), 2006-07, Vol.129 (7), p.E48-E48

Linazasoro, G

2006

Volltextzugriff (PDF)

1.505 Pathophysiology of levodopa-induced dyskinesia in Parkinson's disease: Role of pre- and postsynaptic mechanisms

Parkinsonism & related disorders, 2007, Vol.13, p.S85-S85

Linazasoro, G

2007

Volltextzugriff (PDF)

Dopaminergic agonists in Parkinson's disease

Neurologia (Barcelona, Spain), 2014-05, Vol.29 (4), p.230

2014

Volltextzugriff (PDF)

Onset of dopaminergic therapy in Parkinson's disease: six good reasons not to delay it

Neurología (Barcelona, Spain), 2008-06, Vol.23 (5), p.299-305

Linazasoro, G

2008

Volltextzugriff (PDF)

Rasagiline in Parkinson's disease

Neurología (Barcelona, Spain), 2008-05, Vol.23 (4), p.238

Linazasoro, G

2008

Volltextzugriff (PDF)

If I were to wake up clumsy and shaking (10 years later)

Neurología (Barcelona, Spain), 2008-09, Vol.23 (7), p.449-455

Linazasoro, G

2008

Volltextzugriff (PDF)

Conversion from dopamine agonists to pramipexole

Journal of neurology, 2004-03, Vol.251 (3), p.335-339

Linazasoro, G.

2004

Volltextzugriff (PDF)

Tonegawa syndrome

Neurología (Barcelona, Spain), 2007-05, Vol.22 (4), p.265-265

Linazasoro, G

2007

Volltextzugriff (PDF)

New ideas on the origin of L-dopa-induced dyskinesias: age, genes and neural plasticity

Trends in pharmacological sciences (Regular ed.), 2005-08, Vol.26 (8), p.391-397

Linazasoro, Gurutz

2005

Volltextzugriff (PDF)

Should levodopa dose be reduced when switched to stalevo?

European journal of neurology, 2008-03, Vol.15 (3), p.257-261

2008

Volltextzugriff (PDF)

Worsening of Parkinson's disease by citalopram

Parkinsonism & related disorders, 2000-04, Vol.6 (2), p.111-113

Linazasoro, G

2000

Volltextzugriff (PDF)

Severe stuttering and motor tics responsive to cocaine

Parkinsonism & related disorders, 2007-02, Vol.13 (1), p.57-58

2007

Volltextzugriff (PDF)

Bilateral deep brain stimulation of the subthalamic nucleus in Parkinson's disease

Neurology, 2000, Vol.55 (12 Suppl 6), p.S45

2000

Volltextzugriff (PDF)

Agonistas dopaminérgicos en la enfermedad de Parkinson

Neurología (Barcelona, Spain), 2014-05, Vol.29 (4), p.230-241

2014

Volltextzugriff (PDF)

Dopamine agonist therapy in Parkinson’s disease: Spanish expert consensus on its use in different clinical situations

Neurología (Barcelona, English ed. ), 2023-07

2023

Volltextzugriff (PDF)

PET studies and physiopathology of motor fluctuations in Parkinson's disease

Brain (London, England : 1878), 2004-08, Vol.127 (8), p.e15-e15

2004

Volltextzugriff (PDF)

Dopamine dysregulation syndrome and levodopa-induced dyskinesias in Parkinson disease: common consequences of anomalous forms of neural plasticity

Clinical neuropharmacology, 2009-01, Vol.32 (1), p.22-27

Linazasoro, Gurutz

2009

Volltextzugriff (PDF)

1.503 Genetics, plasticity and dyskinesia in PD

Parkinsonism & related disorders, 2007, Vol.13, p.S84-S84

2007

Volltextzugriff (PDF)

1 – 25 von 148

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(137)
Mit Volltextzugriff
(99)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(115)
Science & Technology
(94)
Life Sciences & Biomedicine
(93)
Neurosciences & Neurology
(84)
Clinical Neurology
(82)
Female
(55)
Male
(53)
Middle Aged
(47)
Aged
(46)
Parkinson Disease - Drug Therapy
(45)
Neurology
(35)
Parkinson's Disease
(34)
Parkinson Disease - Physiopathology
(33)
Biological And Medical Sciences
(28)
Medical Sciences
(28)
Antiparkinson Agents - Therapeutic Use
(25)
Adult
(23)
Levodopa - Therapeutic Use
(18)
Parkinson Disease - Surgery
(17)
Animals
(16)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Potential applications of nanotechnologies to Parkinson's disease therapy

A global view of Parkinson's disease pathogenesis: Implications for natural history and neuroprotection

Classical Parkinson disease versus Parkinson complex - Reflections against staging and in favour of heterogeneity

Imaging beta-amyloid burden in aging and dementia

The phenotypic spectrum of rapid-onset dystonia-parkinsonism (RDP) and mutations in the ATP1A3 gene

Conversion from dopamine agonists to pramipexole: An open-label trial in 227 patients with advanced Parkinson's disease

Classifying risk factors for dyskinesia in Parkinson’s disease

Rate of progression determines the clinical outcome after neural transplantation in Parkinson's disease

1.505 Pathophysiology of levodopa-induced dyskinesia in Parkinson's disease: Role of pre- and postsynaptic mechanisms

Dopaminergic agonists in Parkinson's disease

Onset of dopaminergic therapy in Parkinson's disease: six good reasons not to delay it

Rasagiline in Parkinson's disease

If I were to wake up clumsy and shaking (10 years later)

Conversion from dopamine agonists to pramipexole

Tonegawa syndrome

New ideas on the origin of L-dopa-induced dyskinesias: age, genes and neural plasticity

Should levodopa dose be reduced when switched to stalevo?

Worsening of Parkinson's disease by citalopram

Severe stuttering and motor tics responsive to cocaine

Bilateral deep brain stimulation of the subthalamic nucleus in Parkinson's disease

Agonistas dopaminérgicos en la enfermedad de Parkinson

Dopamine agonist therapy in Parkinson’s disease: Spanish expert consensus on its use in different clinical situations

PET studies and physiopathology of motor fluctuations in Parkinson's disease

Dopamine dysregulation syndrome and levodopa-induced dyskinesias in Parkinson disease: common consequences of anomalous forms of neural plasticity

1.503 Genetics, plasticity and dyskinesia in PD

Suchergebnisse filtern